Trial NCT01284335

View at ClinicalTrials.gov 
Org. Study IDs: 12267
Secondary IDs: H8K-MC-JZAK

Last trial update was posted on 2019-01-10

MeSH Interventions

Docetaxel Erlotinib Hydrochloride Gemcitabine Temozolomide

MeSH Conditions

Neoplasms

Other Conditions

Advanced Solid Tumors

Stopping Reasons

Study was terminated due to the termination of tasisulam development.

Limitations And Caveats

This study was terminated early due to termination of development of the tasisulam compound. All participants were considered to have completed the study upon the completion of one cycle of treatment.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID